Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NuuVim vs WellMedr

By GLP-1 ScorecardUpdated

NuuVim
Site position #113

Higher grade

WellMedr
Site position #221

Lower grade

Score comparison

NuuVim has the higher recorded score — 70.6/100 to 63.2/100.

NuuVim grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NuuVim is a Texas-based DTC telehealth program offering compounded semaglutide and tirzepatide in both injectable and oral forms — oral access is uncommon here — plus limited brand-name Ozempic and Zepbound.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueNuuVim +30
88
58
Dose & formulationNuuVim +22
96
74
Clinical oversightWellMedr +17
54
71
Labs & monitoringWellMedr +8
50
58
FulfillmentWellMedr +1
61
62
Contract termsNuuVim +3
47
44
NuuVim · top barWellMedr · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricNuuVimWellMedr
WeighScore70.6/10063.2/100
GradeCC
Site position#113#221
Semaglutide$79/mo (all doses, 3-mo plan, new patients only, compounded)Advertised from $49/month; selected upfront total, plan term and renewal amount need confirmation
Tirzepatide$133/mo (all doses, 3-mo plan, new patients only, compounded)Advertised from $89/month; selected upfront total, plan term and renewal amount need confirmation
CoverageCoverage not publishedGeneral service page lists all 50 states, DC, Puerto Rico and Guam; exact medication, clinical eligibility and pharmacy fulfillment remain conditional
Brand-name accessYesYes
Oral / sublingualYesYes
NuuVim

Site position #113 · C

Strengths

  • Low compounded entry pricing — semaglutide from $79/mo, tirzepatide from $133/mo, flat all-dose pricing
  • Both injectable and oral compounded options for semaglutide and tirzepatide (oral access is uncommon)
  • LegitScript Certified and HIPAA-compliant
  • Two named compounding pharmacy partners (Hallandale Pharmacy and Pharmacy Hub), both vetted in our directory
  • Operating legal entity disclosed: NuuVim LLC, Texas governing law

What to consider

  • There is no month-to-month plan: every rate is billed as one three-month payment
  • The advertised $79 and $133 are introductory rates for customers new to GLP-1s; on renewal they become $133 and $199.67
  • The site's own llms.txt advertises pricing, FAQ and terms files that all 404
  • No state count is published
WellMedr

Site position #221 · C

Strengths

  • Publishes separate descriptions of 21-day billing and fully prepaid three-, six- and twelve-month plans
  • The refund policy provides detailed renewal and unused-prepayment rules, although important provisions conflict with the Terms
  • Current documents name possible pharmacy partners, including Logos, Emerald and Center City; the assigned facility still needs confirmation
  • The safety page distinguishes compounded preparations from FDA-approved products rather than treating shared ingredients as proof of equivalence

What to consider

  • Starting $49 and $89 advertisements do not establish the total due today, renewal amount or usable prescription supply; confirm whether membership and medication are separate charges
  • Four-week shipping is not the billing calendar; the separately described 21-day plan can generate more frequent charges
  • The refund policy accepts cancellation before a charge is submitted, while the Terms require two days’ notice and allow early renewal processing
  • Unused-prepayment allocation in the refund policy conflicts with discretionary partial refunds, medication-plan cancellation windows and a nonrefundable first membership month in the Terms; no legal priority is established
  • The ninety-day results-refund promise conflicts with policy language denying a results guarantee; clarify the selected written agreement
  • The current directory does not establish an available oral or microdose GLP-1 purchase; the homepage labels microdose Coming soon
  • Current documents do not identify the assigned clinical practice, clinician, dispenser or physical compounder; general service coverage does not guarantee every preparation

Featured provider

WellMedr

WellMedr scores 63.2/100 (C). Advertises low starting prices, but its 21-day and prepaid payment choices come with conflicting cancellation and refund terms; confirm the full bill and selected written agreement before committing.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard